DE60332393D1 - Flüssige pharmazeutische zusammensetzung mit pyridonderivaten - Google Patents
Flüssige pharmazeutische zusammensetzung mit pyridonderivatenInfo
- Publication number
- DE60332393D1 DE60332393D1 DE60332393T DE60332393T DE60332393D1 DE 60332393 D1 DE60332393 D1 DE 60332393D1 DE 60332393 T DE60332393 T DE 60332393T DE 60332393 T DE60332393 T DE 60332393T DE 60332393 D1 DE60332393 D1 DE 60332393D1
- Authority
- DE
- Germany
- Prior art keywords
- pyridide
- derivatives
- pharmaceutical composition
- liquid pharmaceutical
- liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000007788 liquid Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002375834A JP4542743B2 (ja) | 2002-12-26 | 2002-12-26 | ピリドン誘導体の溶液状医薬組成物 |
PCT/JP2003/016599 WO2004058256A1 (en) | 2002-12-26 | 2003-12-24 | Pharmaceutical liquid composition containing pyridone derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60332393D1 true DE60332393D1 (de) | 2010-06-10 |
Family
ID=32677349
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60332393T Expired - Lifetime DE60332393D1 (de) | 2002-12-26 | 2003-12-24 | Flüssige pharmazeutische zusammensetzung mit pyridonderivaten |
Country Status (6)
Country | Link |
---|---|
US (1) | US7605173B2 (de) |
EP (1) | EP1575585B1 (de) |
JP (1) | JP4542743B2 (de) |
AU (1) | AU2003292551A1 (de) |
DE (1) | DE60332393D1 (de) |
WO (1) | WO2004058256A1 (de) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003284808B2 (en) * | 2003-11-14 | 2009-01-22 | Catalyst Biosciences, Inc. | The derivatives of pyridone and the use of them |
DK1928454T3 (da) | 2005-05-10 | 2014-11-03 | Intermune Inc | Pyridonderivater til modulering af stress-aktiveret proteinkinasesystem |
US7449441B2 (en) * | 2005-05-18 | 2008-11-11 | Toilex, Llc | Liquid composition for reducing toilet odor |
US7589076B2 (en) * | 2006-05-18 | 2009-09-15 | Pgx Health, Llc | Substituted aryl piperidinylalkynyladenosines as A2AR agonists |
WO2008089426A2 (en) * | 2007-01-19 | 2008-07-24 | Hananja Ehf | Methods and compositions for the delivery of a therapeutic agent |
US20080275030A1 (en) | 2007-01-19 | 2008-11-06 | Sveinbjorn Gizurarson | Methods and Compositions for the Delivery of a Therapeutic Agent |
JP5248040B2 (ja) | 2007-05-25 | 2013-07-31 | リードケミカル株式会社 | 5−メチル−1−フェニル−2−(1h)−ピリドン含有貼付剤 |
WO2008147169A2 (es) * | 2007-05-29 | 2008-12-04 | Cell Therapy Technology, S.A. De C.V. | Microemolsion conteniendo pirfenidona |
MX2007009796A (es) * | 2007-08-14 | 2009-02-25 | Cell Therapy And Technology S | Gel conteniendo pirfenidona. |
EP2296653B1 (de) | 2008-06-03 | 2016-01-27 | Intermune, Inc. | Verbindungen und verfahren zur behandlung von entzündungserkrankungen und fibrotischen erkrankungen |
US7635707B1 (en) | 2008-11-10 | 2009-12-22 | Intermune, Inc. | Pirfenidone treatment for patients with atypical liver function |
JP2010120912A (ja) | 2008-11-21 | 2010-06-03 | Lead Chemical Co Ltd | 5−メチル−1−フェニル−2−(1h)−ピリドン含有貼付剤 |
AU2010206543A1 (en) * | 2009-01-26 | 2011-07-07 | Intermune, Inc. | Methods for treating acute myocardial infarctions and associated disorders |
US8084475B2 (en) * | 2009-12-04 | 2011-12-27 | Intermune, Inc. | Pirfenidone therapy and inducers of cytochrome P450 |
US7816383B1 (en) | 2009-12-04 | 2010-10-19 | Intermune, Inc. | Methods of administering pirfenidone therapy |
US10105356B2 (en) | 2011-01-31 | 2018-10-23 | Avalyn Pharma Inc. | Aerosol pirfenidone and pyridone analog compounds and uses thereof |
AU2012212269B2 (en) * | 2011-01-31 | 2016-05-19 | Avalyn Pharma Inc. | Aerosol pirfenidone and pyridone analog compounds and uses thereof |
EP2877164B1 (de) * | 2012-07-24 | 2023-07-05 | Avalyn Pharma Inc. | Aerosolpirfenidon und pyridonanalogverbindungen |
CA2819967C (en) | 2012-08-31 | 2016-03-22 | Intermune, Inc. | Use of pirfenidone concomitantly with ciprofloxacin |
AR092742A1 (es) | 2012-10-02 | 2015-04-29 | Intermune Inc | Piridinonas antifibroticas |
US20140187635A1 (en) * | 2012-12-28 | 2014-07-03 | Themis Medicare Limited | Diclofenac compositions |
UA119324C2 (uk) * | 2013-04-02 | 2019-06-10 | Теміс Медікер Лімітед | Композиції фармацевтично активних речовин, що містять моноетиловий ефір діетиленгліколю або інші алкільні похідні |
JP6174374B2 (ja) * | 2013-05-22 | 2017-08-02 | 塩野義製薬株式会社 | 吸入用医薬組成物 |
WO2015106150A1 (en) | 2014-01-10 | 2015-07-16 | Genoa Pharmaceuticals Inc. | Aerosol pirfenidone and pyridone analog compounds and uses thereof |
RU2692485C2 (ru) | 2014-04-02 | 2019-06-25 | Интермьюн, Инк. | Противофиброзные пиридиноны |
CA2937365C (en) | 2016-03-29 | 2018-09-18 | F. Hoffmann-La Roche Ag | Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same |
CN109758436A (zh) * | 2017-11-09 | 2019-05-17 | 北京盈科瑞创新药物研究有限公司 | 一种雾化吸入用吡非尼酮冻干脂质体制剂及其制备方法 |
EP4262751A1 (de) * | 2020-12-16 | 2023-10-25 | Cipla Limited | Topische pirfenidonzusammensetzung |
US20230190681A1 (en) * | 2021-12-16 | 2023-06-22 | Hector Gonzales | Topical Ointment Composition, Methods Of Use, And Methods Of Preparation |
CN117653587A (zh) * | 2022-09-06 | 2024-03-08 | 南京迈诺威医药科技有限公司 | 一种含有吡非尼酮的局部外用制剂及其用途 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3839346A (en) * | 1972-12-18 | 1974-10-01 | Affiliated Med Res | N-substituted pyridone and general method for preparing pyridones |
DE2366349C2 (de) * | 1972-12-18 | 1986-03-27 | Affiliated Medical Research Inc., Princeton, N.J. | Verfahren zur Herstellung von 5-Methyl-1-phenyl-2-(1H)-pyridon |
ZA757570B (en) * | 1974-12-09 | 1977-07-27 | Affiliated Med Res | A useful n-substituted pyridone |
JPH02215719A (ja) | 1989-02-15 | 1990-08-28 | Yamauchi Akitomo | 線維化病変組織の修復並びに線維化病変の阻止剤 |
US4973468A (en) * | 1989-03-22 | 1990-11-27 | Cygnus Research Corporation | Skin permeation enhancer compositions |
US5310562A (en) | 1989-11-22 | 1994-05-10 | Margolin Solomon B | Composition and method for reparation and prevention of fibrotic lesions |
DE69431433T2 (de) * | 1993-05-07 | 2003-12-04 | Solomon B Margolin | Zusammensetzungen und verfahren zur reparatur und vorbeugung fibrotischer verletzungen |
DE69917248T2 (de) * | 1998-03-17 | 2005-05-04 | Margolin, Solomon B., Dallas | Topische antiseptische zusammensetzungen und verfahren |
DE69810518D1 (de) * | 1998-09-18 | 2003-02-06 | Mepha Ag Aesch | Topisch verabreichbare alkyl-, phenyl-pyridone-arzneimittel |
US20020086878A1 (en) * | 1999-01-11 | 2002-07-04 | Douglas Joseph Dobrozsi | Compositions having improved stability |
US6087393A (en) * | 1999-06-10 | 2000-07-11 | Igen, Inc. | Stabilized vitamin C formulations |
EP1738749A1 (de) * | 1999-12-23 | 2007-01-03 | Pfizer Products Inc. | Arzneizusammensetzung mit erhöhter arzneistoffkonzentration |
WO2001058448A1 (fr) * | 2000-02-09 | 2001-08-16 | Shionogi & Co., Ltd. | Inhibiteur d'apoptose |
AU2001251650A1 (en) * | 2000-04-18 | 2001-10-30 | Pharmacia Corporation | Rapid-onset formulation of a selective cyclooxigenase-2 |
US20040033257A1 (en) * | 2002-05-30 | 2004-02-19 | Strides Inc. | Pharmaceutical formulation in a drug delivery system and process for preparing the same |
CH696420A5 (de) * | 2002-09-13 | 2007-06-15 | Mepha Ag | Neue stabile Zubereitungen von Alkyl-, Phenyl-Pyridonen für topische Anwendung. |
-
2002
- 2002-12-26 JP JP2002375834A patent/JP4542743B2/ja not_active Expired - Fee Related
-
2003
- 2003-12-24 AU AU2003292551A patent/AU2003292551A1/en not_active Abandoned
- 2003-12-24 EP EP03768187A patent/EP1575585B1/de not_active Expired - Fee Related
- 2003-12-24 US US10/540,422 patent/US7605173B2/en not_active Expired - Fee Related
- 2003-12-24 DE DE60332393T patent/DE60332393D1/de not_active Expired - Lifetime
- 2003-12-24 WO PCT/JP2003/016599 patent/WO2004058256A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
EP1575585B1 (de) | 2010-04-28 |
JP4542743B2 (ja) | 2010-09-15 |
EP1575585A1 (de) | 2005-09-21 |
EP1575585A4 (de) | 2008-04-02 |
US7605173B2 (en) | 2009-10-20 |
AU2003292551A1 (en) | 2004-07-22 |
WO2004058256A1 (en) | 2004-07-15 |
JP2004203795A (ja) | 2004-07-22 |
US20060167064A1 (en) | 2006-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60332393D1 (de) | Flüssige pharmazeutische zusammensetzung mit pyridonderivaten | |
DE602004025950D1 (de) | Pharmazeutische formulierung mit lanthanum-verbindungen | |
DE60213592D1 (de) | Flüssige pharmazeutische zusammensetzung | |
DE60209145D1 (de) | Pharmazeutische formulierungen mit platinderivaten | |
DE602004016444D1 (de) | Azithromycin enthaltende pharmazeutische Zusammensetzungen mit verringerten Nebenwirkungen | |
DE60316323D1 (de) | Feste pharmazeutische formulierungen mit telmisartan | |
DE60118008D1 (de) | Pharmazeutische zusammensetzungen mit amlodipinmaleat | |
DE602004016967D1 (de) | Flüssige pharmazeutische palonosetronformulierungen | |
ATE355271T1 (de) | Pharmazeutische zusammensetzung | |
DK1633388T3 (da) | Flydende stabiliserede interferon-beta-formuleringer i coatede farmaceutiske beholdere | |
ATE307571T1 (de) | Pharmazeutische formulierung enthaltend bicalutamid | |
PT1467724E (pt) | Composicao farmaceutica orodispersavel de agomelatina | |
DE60312049D1 (de) | Stabilisierte pharmazeutische zusammensetzung enthaltend einen amorphen wirkstoff | |
DE602005021475D1 (de) | Magenresistente pharmazeutische dosierform mit n-(2-(2-phthalimidoethoxy)-acetyl)-l-alanyl-d-glutaminsäure (lk-423) | |
ATE477814T1 (de) | Stabile faktor-viii enthaltende pharmazeutische zusammensetzung | |
DE60305728D1 (de) | PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT VERLuNGERTER FREISETZUNG | |
ATE415949T1 (de) | Pharmazeutische formulierung mit levothyroxin- natrium | |
DE60217390D1 (de) | Bicalutamid enthaltende pharmazeutische zusammensetzung | |
DE60336999D1 (de) | Melatonin enthaltende pharmazeutische formulierung | |
DE60310526D1 (de) | Ivabradin enthaltende pharmazeutische zusammensetzung mit oraler dispersion | |
DE60306747D1 (de) | Perindopril enthaltende pharmazeutische zusammensetzung mit oraler dispersion | |
DE60136367D1 (de) | Pharmazeutische zusammensetzung mit modifiziertem träger | |
ATE489943T1 (de) | Pharmazeutische zusammensetzung mit 2,3-dihydro-6-nitroimidazoä2,1-büoxazolderivate | |
DE10291905D2 (de) | Pharmazeutische Zusammensetzung | |
ATE350029T1 (de) | Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |